InvestSMART

HeraMED Limited (ASX: HMD) - Announcements

- Current share price for HMD : $0.034

ASX company news and announcements for HeraMED Limited (HMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All HeraMED Limited (HMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than HeraMED Limited (HMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for HeraMED Limited (HMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$39 HMD passes first stage for Israel Innovation Authority Grant 24 Sep 2019 8:34AM $0.155 $0.034 fallen by 78.06%
$39 HeraMED and Mayo Clinic to co-develop a New Platform 17 Sep 2019 9:26AM $0.165 $0.034 fallen by 79.39%
$39 Global Distribution Progress Update 4 Sep 2019 8:27AM $0.170 $0.034 fallen by 80%
$39 Appendix 3B 28 Aug 2019 4:17PM $0.180 $0.034 fallen by 81.11%
$39 HeraMED Solutions Operational Across Multiple Hapvida Sites 28 Aug 2019 9:18AM $0.160 $0.034 fallen by 78.75%
$39 Appendix 4D and Half Year Report 28 Aug 2019 9:01AM $0.160 $0.034 fallen by 78.75%
$39 Correction to Appendix 4C 14 Aug 2019 8:17AM $0.190 $0.034 fallen by 82.11%
$39 HeraMED enters the German market with initial PO secured 12 Aug 2019 8:20AM $0.190 $0.034 fallen by 82.11%
$39 June Quarterly Activities Report & Appendix 4C 31 Jul 2019 8:39AM $0.210 $0.034 fallen by 83.81%
$39 HeraCARE Investor Presentation July 2019 22 Jul 2019 8:23AM $0.190 $0.034 fallen by 82.11%
$39 HeraCARE PRO Integrated into Hapvidas Hospital Systems 1 Jul 2019 8:31AM $0.190 $0.034 fallen by 82.11%
$39 HeraBEAT Australian B2C launch underway 19 Jun 2019 9:32AM $0.210 $0.034 fallen by 83.81%
$39 Appendix 3B 14 Jun 2019 2:28PM $0.230 $0.034 fallen by 85.22%
$39 Appendix 3B 6 Jun 2019 5:21PM $0.250 $0.034 fallen by 86.40%
$39 Appendix 3B 3 Jun 2019 5:04PM $0.245 $0.034 fallen by 86.12%
$39 Release of Securities from Escrow 31 May 2019 11:08AM $0.260 $0.034 fallen by 86.92%
$39 Results of Annual General Meeting 29 May 2019 10:38AM $0.280 $0.034 fallen by 87.86%
$39 Annual General Meeting Venue Room Update 24 May 2019 9:35AM $0.250 $0.034 fallen by 86.40%
$39 Dr Friedman joins HeraMED advisory board 20 May 2019 11:15AM $0.255 $0.034 fallen by 86.67%
$39 HeraMED to launch HeraBEAT in Mexico 15 May 2019 12:32PM $0.250 $0.034 fallen by 86.40%
$39 Company Presentation May 2019 14 May 2019 2:37PM $0.240 $0.034 fallen by 85.83%
$39 Release of Securities from Escrow 9 May 2019 11:00AM $0.250 $0.034 fallen by 86.40%
$39 HeraMED Expands European Distribution Network Clarification 8 May 2019 2:27PM $0.250 $0.034 fallen by 86.40%
$39 HeraMED Expands European Distribution Network 8 May 2019 9:03AM $0.250 $0.034 fallen by 86.40%
$39 HeraMED begins FDA Approval Process for HeraBEAT 29 Apr 2019 8:35AM $0.230 $0.034 fallen by 85.22%

476 - 500 of 541 results

Page 20 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.